Hunan Fangsheng Pharm Co Ltd (603998) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Hunan Fangsheng Pharm Co Ltd (603998) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥95.63 Million ≈ $13.99 Million USD) by net assets (CN¥1.75 Billion ≈ $256.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Hunan Fangsheng Pharm Co Ltd (603998) total market value for the company's overall valuation and market capitalisation.

Hunan Fangsheng Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Hunan Fangsheng Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hunan Fangsheng Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Fangsheng Pharm Co Ltd ranked by their cash flow conversion efficiency. Explore Hunan Fangsheng Pharm Co Ltd (603998) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Zhejiang Yankon Group Co Ltd SHG:600261	0.022x
Kvutzat Acro Ltd. TA:ACRO	-0.030x
Hanwha Investment&Securities Co Ltd KO:003530	-0.108x
LiJiang YuLong Tourism Co Ltd SHE:002033	0.071x
Chahua Modern Housewares Co Ltd SHG:603615	-0.105x
CHINA VANKE CO.LTD H YC 1 F:18V	N/A
Hemnet Group AB ST:HEM	0.154x
Udemy Inc NASDAQ:UDMY	0.074x

Annual Cash Flow Conversion Efficiency for Hunan Fangsheng Pharm Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Hunan Fangsheng Pharm Co Ltd from 2011 to 2025. View 603998 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.80 Billion ≈ $263.81 Million	CN¥384.63 Million ≈ $56.28 Million	0.213x	+89.86%
2024-12-31	CN¥1.73 Billion ≈ $253.87 Million	CN¥194.95 Million ≈ $28.53 Million	0.112x	+103.94%
2023-12-31	CN¥1.59 Billion ≈ $232.48 Million	CN¥87.54 Million ≈ $12.81 Million	0.055x	-72.45%
2022-12-31	CN¥1.51 Billion ≈ $220.66 Million	CN¥301.63 Million ≈ $44.14 Million	0.200x	+40.48%
2021-12-31	CN¥1.30 Billion ≈ $190.76 Million	CN¥185.63 Million ≈ $27.16 Million	0.142x	-23.85%
2020-12-31	CN¥1.27 Billion ≈ $185.22 Million	CN¥236.66 Million ≈ $34.63 Million	0.187x	+38.29%
2019-12-31	CN¥1.20 Billion ≈ $175.95 Million	CN¥162.58 Million ≈ $23.79 Million	0.135x	-14.54%
2018-12-31	CN¥1.11 Billion ≈ $162.84 Million	CN¥176.06 Million ≈ $25.76 Million	0.158x	+925.77%
2017-12-31	CN¥1.04 Billion ≈ $151.83 Million	CN¥16.00 Million ≈ $2.34 Million	0.015x	-87.27%
2016-12-31	CN¥979.69 Million ≈ $143.36 Million	CN¥118.70 Million ≈ $17.37 Million	0.121x	+24.64%
2015-12-31	CN¥931.73 Million ≈ $136.34 Million	CN¥90.57 Million ≈ $13.25 Million	0.097x	-13.08%
2014-12-31	CN¥841.94 Million ≈ $123.20 Million	CN¥94.16 Million ≈ $13.78 Million	0.112x	-64.82%
2013-12-31	CN¥386.85 Million ≈ $56.61 Million	CN¥122.97 Million ≈ $17.99 Million	0.318x	+318.63%
2012-12-31	CN¥318.83 Million ≈ $46.66 Million	CN¥24.21 Million ≈ $3.54 Million	0.076x	-69.88%
2011-12-31	CN¥258.49 Million ≈ $37.83 Million	CN¥65.16 Million ≈ $9.54 Million	0.252x	--

About Hunan Fangsheng Pharm Co Ltd

SHG:603998 China Drug Manufacturers - Specialty & Generic

Market Cap

$675.92 Million

CN¥4.62 Billion CNY

Market Cap Rank

#10908 Global

#3039 in China

Share Price

CN¥10.52

Change (1 day)

-1.77%

52-Week Range

CN¥8.85 - CN¥13.01

All Time High

CN¥18.09